Filing Details
- Accession Number:
- 0001127602-13-025752
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-21 16:55:44
- Reporting Period:
- 2013-08-19
- Filing Date:
- 2013-08-21
- Accepted Time:
- 2013-08-21 16:55:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1267878 | W Todd Kingma | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-19 | 4,106 | $118.74 | 21,171 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-19 | 1,298 | $118.74 | 19,873 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-08-20 | 2,500 | $118.55 | 17,373 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-08-20 | 308 | $119.23 | 17,065 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2013-08-19 | 4,106 | $0.00 | 4,106 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-08-19 | 2013-08-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 961 | Indirect | By Trust |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
- The price in column 4 is a weighted average. The prices actually received ranged from $118.17 to $119.13. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $119.22 to $119.40. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- By Trust, of which the reporting person is the Trustee.
- Vesting of Restricted Stock Units granted on August 19, 2010.